author-photo

Kay L. Richards

Florey Institute of Neuroscience and Mental Health
University of Melbourne

39

Papers

665

Citations

Citation Trend

Filter By

Papers (22) Sort By

Journal Conference Others

Antisense oligonucleotide therapy reduces seizures and extends life span in an SCN2A gain-of-function epilepsy model.

2021 Journal of Clinical Investigation
Show All
- Source
- Cite
- Save
Citations (1)
Glass-brain mapping provides an adjunct tool for structural analysis in mouse models of neurodevelopmental disease

2021
Show All
- Source
- Cite
- Save
Citations (0)
Atypical myelinogenesis and reduced axon caliber in the Scn1a variant model of Dravet syndrome: An electron microscopy pilot study of the developing and mature mouse corpus callosum.

2020 Brain Research
Show All
- Source
- Cite
- Save
Citations (1)
Antisense oligonucleotide therapy for SCN2A gain-of-function epilepsy

2020 bioRxiv
Show All
- Source
- Cite
- Save
Citations (8)
Dysmorphic neuron density is highest in the centre of epileptogenic cortical tubers

2019 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Using a Multiplex Nucleic Acid in situ Hybridization Technique to Determine HCN4 mRNA Expression in the Adult Rodent Brain

2019 Frontiers in Molecular Neuroscience
Show All
- Source
- Cite
- Save
Citations (9)
Characterization of a Novel Knock-in Mouse Model of KCNT1 Epileptic Encephalopathy

2018 Neurology
Show All
- Source
- Cite
- Save
Citations (1)
Dravet and GEFS+ Syndromes

2017
- Kay L. Richards
- Steve Petrou
Show All
- Source
- Cite
- Save
Citations (1)
Dravet and GEFS plus Syndromes

2017
- Kay L. Richards
- Steve Petrou
Show All
- Source
- Cite
- Save
Citations (0)
Rare and common epilepsies converge on a shared gene regulatory network providing opportunities for novel antiepileptic drug discovery

2016 Genome Biology
Show All
- Source
- Cite
- Save
Citations (54)